YHR212W-A Antibody

What is YHR212W-A and why is it significant for yeast research?

YHR212W-A is an uncharacterized protein in Saccharomyces cerevisiae (baker's yeast), specifically identified in strain ATCC 204508/S288c. It represents a pseudogenic fragment with similarity to flocculins that was identified through gene-trapping, microarray-based expression analysis, and genome-wide homology searching . The protein is significant because it represents one of the previously overlooked genes in yeast that may contribute to our understanding of genome organization and evolution.

When studying YHR212W-A, researchers should note that SWAT-GFP, seamless-GFP, and mCherry fusion proteins localize to the endoplasmic reticulum, suggesting a potential membrane-associated role . Additionally, YHR212W-A has a paralog, YAR061W, that arose from a segmental duplication, which offers interesting comparative study opportunities for gene duplication research.

What experimental methods are best suited for detecting YHR212W-A expression in yeast cells?

For detecting YHR212W-A expression, researchers should consider a multi-method approach:

• Immunoblotting (Western blot) using YHR212W-A antibodies (e.g., CSB-PA819496XA01SVG)

• Indirect immunofluorescence microscopy using epitope-tagged proteins

• RNA microarray analysis for transcriptomic profiling

For immunofluorescence detection, following the methodology described in the literature for HA-tagged proteins can be effective: use mouse monoclonal anti-HA antibodies (such as 16B12) followed by Cy3-conjugated goat anti-mouse IgG for visualization . This approach allows for subcellular localization studies, which is particularly valuable given YHR212W-A's localization to the endoplasmic reticulum.

For RNA expression analysis, extraction from yeast strains grown to late-log phase in appropriate media, followed by microarray analysis, can provide insights into transcriptional regulation patterns .

How should I optimize immunoprecipitation protocols when working with YHR212W-A antibodies?

When optimizing immunoprecipitation (IP) protocols for YHR212W-A antibodies, consider these methodological adjustments:

• Cell lysis optimization: Since YHR212W-A localizes to the endoplasmic reticulum, use lysis buffers containing 1% NP-40 or Triton X-100 with protease inhibitors to effectively solubilize membrane components without denaturing the antibody epitopes.

• Antibody binding conditions: Due to the uncharacterized nature of the protein, test multiple binding conditions:

  • Standard overnight incubation at 4°C

  • Shorter incubations (4 hours) at room temperature

  • Various antibody concentrations (1-5 μg per sample)

• Bead selection: Compare Protein A/G magnetic beads versus agarose beads for optimal capture efficiency.

• Washing stringency gradient: Implement a stringency gradient during wash steps to determine optimal conditions that remove non-specific binding while preserving specific interactions.

Document all optimization steps systematically to establish a reproducible protocol specific to YHR212W-A studies.

What controls are essential when validating YHR212W-A antibody specificity for immunofluorescence microscopy?

For rigorous validation of YHR212W-A antibody specificity in immunofluorescence applications, the following controls are essential:

• Genetic knockout/deletion control: Use a YHR212W-A deletion strain to confirm absence of signal when the target protein is not present.

• Pre-absorption control: Pre-incubate the antibody with purified YHR212W-A protein prior to immunostaining to demonstrate signal reduction.

• Secondary antibody-only control: Omit primary antibody to assess non-specific binding of the secondary antibody.

• Cross-reactivity assessment: Test the antibody against strains expressing only the paralog YAR061W to evaluate potential cross-reactivity.

• Epitope-tagged verification: Compare localization patterns between antibody staining and direct visualization of GFP/mCherry-tagged YHR212W-A .

These controls are particularly important for YHR212W-A given its uncharacterized nature and the presence of a paralog with high sequence similarity.

How can YHR212W-A antibodies be utilized in studies investigating gene duplication and paralog functional divergence?

YHR212W-A offers an excellent model for studying gene duplication and paralog functional divergence due to its relationship with YAR061W. Methodological approaches include:

• Comparative immunoprecipitation: Use both YHR212W-A and YAR061W antibodies to identify shared versus unique interaction partners, revealing functional conservation or divergence.

• ChIP-seq comparative analysis: If either paralog functions in transcriptional regulation, chromatin immunoprecipitation sequencing can map binding sites across the genome, revealing target gene differences.

• Evolutionary rate analysis: Combine antibody-based protein quantification with computational analysis of evolutionary rates between paralogs to assess selection pressures.

• Double knockout phenotyping: Create single and double knockouts, then use antibodies to validate deletion and assess compensatory protein expression changes in other pathways.

These approaches can illuminate how gene duplications contribute to evolutionary innovation and functional redundancy in yeast systems.

What are the most effective strategies for coupling YHR212W-A antibodies with mass spectrometry for interactome studies?

For comprehensive YHR212W-A interactome mapping using antibody-coupled mass spectrometry, implement the following strategic methodology:

• Crosslinking immunoprecipitation (CLIP-MS):

  • Use formaldehyde or DSS crosslinkers (0.1-1%) to capture transient interactions

  • Perform IP with YHR212W-A antibodies

  • Process samples through on-bead digestion with trypsin

  • Analyze peptides using LC-MS/MS with high-resolution instruments

• Quantitative comparative approach:

  • Compare YHR212W-A pulldowns against:

    • Negative controls (non-specific IgG)

    • Parallel YAR061W antibody pulldowns

    • Empty vector controls

• Validation workflow:

  • Filter hits using computational scoring (SAINT score >0.9)

  • Confirm top interactions through reciprocal IP

  • Verify co-localization to the endoplasmic reticulum

This integrated workflow enhances specificity and biological relevance of identified interactions, particularly important for uncharacterized proteins like YHR212W-A.

How can researchers address high background issues when using YHR212W-A antibodies in Western blots?

When encountering high background with YHR212W-A antibodies in Western blotting, implement this systematic troubleshooting approach:

• Blocking optimization:

  • Test different blocking agents: 5% BSA versus 5% non-fat dry milk

  • Increase blocking time to 2 hours at room temperature

  • Add 0.05-0.1% Tween-20 to blocking buffer

• Antibody dilution series:

  • Create a gradient of primary antibody dilutions (1:500 to 1:5000)

  • Optimize secondary antibody concentration independently

  • Consider adding 0.1-0.2% SDS to antibody diluent to reduce non-specific binding

• Membrane washing protocol enhancement:

  • Increase number of washes (5-6 times)

  • Extend each wash duration to 10 minutes

  • Use TBS-T with 0.1-0.3% Tween-20

• Sample preparation refinement:

  • Ensure complete denaturation of membrane proteins

  • Add reducing agents fresh before loading

  • Consider membrane protein enrichment methods before SDS-PAGE

Document results systematically to establish optimal conditions for specific detection of the uncharacterized YHR212W-A protein.

What considerations should be made when designing experiments to distinguish between YHR212W-A and its paralog YAR061W?

Distinguishing between YHR212W-A and its paralog YAR061W requires careful experimental design due to their sequence similarity. Implement these methodological approaches:

• Epitope mapping and antibody selection:

  • Identify unique epitope regions through sequence alignment

  • Develop and validate epitope-specific antibodies

  • Test antibody specificity on overexpression systems of each paralog

• Knockout validation approach:

  • Create individual knockout strains for each paralog

  • Perform Western blots and immunofluorescence on both strains

  • Verify signal absence in respective knockout backgrounds

• MS-based distinction:

  • Identify unique peptides specific to each paralog

  • Develop targeted mass spectrometry methods (MRM/PRM)

  • Quantify paralog-specific peptides for differential expression analysis

• Location-based differentiation:

  • Use subcellular fractionation coupled with immunoblotting

  • Perform high-resolution co-localization studies

  • Compare interaction partners to infer functional differences

These approaches allow researchers to confidently distinguish between these closely related proteins and their respective functions.

How can YHR212W-A antibodies be incorporated into active learning approaches for improving binding prediction models?

YHR212W-A antibodies can serve as valuable test cases for active learning approaches in antibody-antigen binding prediction models, following methodologies similar to those described in recent research:

• Library-on-library screening integration:

  • Include YHR212W-A in antigen libraries for many-to-many relationship modeling

  • Generate binding data through high-throughput screening techniques

  • Use resulting data as training inputs for machine learning models

• Implementation of iterative strategy selection:

  • Begin with small labeled dataset of YHR212W-A binding interactions

  • Apply active learning algorithms to select most informative experiments

  • Reduce experimental costs by up to 35% through strategic data acquisition

• Out-of-distribution testing:

  • Evaluate model performance when YHR212W-A variants are not represented in training data

  • Compare algorithm performance against random baseline selection

  • Measure efficiency improvements through reduced experimental iterations

This approach not only advances YHR212W-A research but contributes to broader antibody engineering methodologies.

What are the implications of using YHR212W-A antibodies in studies of overlooked genes and pseudogenic fragments?

Using YHR212W-A antibodies in studies of overlooked genes has several methodological implications and research opportunities:

• Integration with genome-wide screening approaches:

  • Combine YHR212W-A antibody detection with transposon-based mutagenesis

  • Implement β-galactosidase reporter assays for gene expression analysis

  • Use ORFSEEK or similar computational tools to identify and characterize full-length ORFs

• Evolutionary significance assessment:

  • Compare expression patterns across related yeast species

  • Investigate selection pressures on pseudogenic fragments

  • Evaluate functional constraints through comparative proteomic analyses

• Methodological framework for studying uncharacterized proteins:

  • Establish a pipeline combining antibody validation, localization studies, and functional assays

  • Develop criteria for distinguishing functional pseudogenes from non-functional fragments

  • Create standardized reporting formats for overlooked gene characterization

This research direction contributes to our understanding of genome complexity and evolution, potentially revealing new functional elements within genomes previously considered "junk DNA."

How can structural studies benefit from YHR212W-A antibodies, particularly in relation to the YYDRxG motif found in other antibodies?

Though YHR212W-A is not directly related to the YYDRxG motif found in SARS-CoV-2 neutralizing antibodies, there are methodological parallels that can inform structural studies:

• Comparative structural analysis methodology:

  • Similar to how YYDRxG motif was identified through structural characterization of antibodies

  • Apply X-ray crystallography techniques to YHR212W-A complexes with binding partners

  • Search for recurring structural motifs that might indicate conserved binding mechanisms

• Epitope mapping strategy:

  • Use YHR212W-A antibodies to identify critical binding regions

  • Implement computational pattern searching similar to that used for YYDRxG motif

  • Assess whether specific epitopes are conserved across related yeast proteins

• Functional conservation assessment:

  • Evaluate whether YHR212W-A contains functionally conserved epitopes similar to conserved regions in virus-targeting antibodies

  • Test cross-reactivity with related proteins to identify convergent binding solutions

  • Investigate whether such motifs represent evolutionary convergence in protein recognition

These approaches demonstrate how structural methodologies developed in other fields can be adapted to study uncharacterized yeast proteins.